New drug trial offers hope for Tough-to-Treat cancers
Disease control
Recruiting now
This early-stage study is testing a new drug called VT3989, both alone and in combination with other cancer therapies. It aims to find a safe dose and see if it can help control advanced solid tumors and mesothelioma that have stopped responding to standard treatments. The trial …
Phase: PHASE1, PHASE2 • Sponsor: Vivace Therapeutics, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC